Disseminated histoplasmosis in non-immunocompromised children: A scoping review - 20/11/26

Abstract |
Reviews describing the occurrence of histoplasmosis in immunocompetent children are lacking in the literature despite case reports documented globally. We conducted a comprehensive literature search following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews guidelines to identify individual cases and series on histoplasmosis in immunocompetent children published between January 2001 and October 2025. We identified 30 cases from India (n=10, 33.3%), USA (n=7, 23.3%), Nigeria (=2, 6.7%), Brazil (n=2, 6.7%), China (n=2, 6.7%), Argentina (n=1, 3,3%), Chad Republic (n=1, 3.3%), Georgia (n=1, 3.3%), Mexico (n=1, 3.3%), Costa-Rica (n=1, 3.3%), Paraguay (n=1, 3.3%) and Colombia (n=1, 3.3%). The risk factors were unknown or not reported in most cases. The spectrum of diagnosis was predominantly disseminated histoplasmosis (n=22, 73.3%) followed by pulmonary histoplasmosis (n=2, 6.7%). Outcomes were favourable in 24 (80.0%) cases, three (10.0%) were fatal cases, one (3.3%) was lost to follow-up, and outcomes were not specified in two (n=2, 6.7%). Our findings suggest histoplasmosis can also be encountered in non-immunocompromised children. It should be considered as a differential in children, especially in endemic settings, regardless of their immune status or in the absence of risk factors.
Le texte complet de cet article est disponible en PDF.Keywords : Immunocompetent, Immunocompromised, Children, Histoplasmosis, Diagnosis
Plan
Vol 37 - N° 1
Article 101673- mars 2027 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
